Zimmerman, B., Dakin, L. A., Fortier, A., Nanou, E., Blasio, A., Mann, J., Miller, H., Fletcher, M., Wang, T., Nanthakumar, S., McCarthy, G., Matar, C., Matsye, P., Wang, G., Snyder, P., Daniel, K., Swamy, H., Sullivan, K., Bright, F., Powers, A., Gagnon, K. J., Lu, F., Paula, S., Khare-Pandit, S., Henry, L., Hamel, M., Denis, F., Nicolas, O., Hariparsad, N., Kumar, S., Proctor, J., Senter, T., Furey, B., Bunnage, M. E. (2025). Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease. Nature Communications. https://doi.org/10.1038/s41467-024-55408-2